Inactivity for Metabolic Diseases
Trial Summary
What is the purpose of this trial?
Fitness is one of the best predictors for heart and brain disease. To increase ones fitness, the American Heart Association (AHA) says to exercise at least 150 minutes per week or 75 minutes per week if really hard. These exercise guides are pretty effective, however not everyone will get the same results. What individuals do outside of the exercise bout can influence the effectiveness of exercise. One of these factors is our time sitting, which has caused the phrase "sitting is the new smoking". Other studies have said that the metabolic benefits of exercise are decreased when you exercise after a few days of low activity (less than 5,000 steps per day). This is important in that exercise may not be able to fully offset these times of inactivity. However, these studies were only looking at different fats in the blood. As exercise increases fat burn up to 10 times in the muscle, more research is needed to understand how inactivity affects the muscle during exercise and after exercise. This study will help answer two questions: 1) How does a day of sitting a lot affect the muscle's ability to respond to exercise? and 2) How does a day of sitting a lot affect carbohydrate and fat burn during and after a bout of exercise? The investigators will answer these questions by having people complete one day of inactivity (less than 5,000 steps) or normal activity (more than 8,500 steps). Subjects will then come in the next day to bike somewhat hard for 1 hour. The investigators will take blood samples before, during, and after exercise to measure energy sources. The investigators will also collect pieces of skeletal muscle before and after exercise to see how the muscle responded to exercise. This study is significant for the publication of exercise guidelines to minimize risk of heart and metabolic diseases.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Inactivity for metabolic diseases?
Is inactivity safe for humans?
How does the treatment 'Inactivity' differ from other treatments for metabolic diseases?
The treatment 'Inactivity' is unique because it focuses on the role of physical inactivity itself as a contributing factor to metabolic diseases, unlike other treatments that typically involve increasing physical activity or dietary changes. This approach highlights the impact of reduced movement on insulin resistance and obesity, offering a novel perspective on managing these conditions.16101112
Eligibility Criteria
This trial is for individuals who are interested in how a day of sitting affects muscle response to exercise and energy use during and after cycling. Participants should be able to complete one day with less than 5,000 steps followed by an hour of biking. The study requires blood samples and muscle biopsies before and after exercise.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-Exercise Activity Monitoring
Participants are monitored for activity levels, either being sedentary (<5,000 steps) or maintaining normal activity (>8,500 steps) prior to exercise
Exercise and Sample Collection
Participants perform a 1-hour cycling exercise with blood and muscle samples collected before, during, and after exercise
Follow-up
Participants are monitored for changes in gene expression and metabolism up to 4 hours post-exercise
Treatment Details
Interventions
- Inactivity
Find a Clinic Near You
Who Is Running the Clinical Trial?
Concordia University Wisconsin
Lead Sponsor